| | Prostaglandin Receptor Ligands
- AH-6809
A prostaglandin DP-receptor inhibitor. The compound has been reported to antagonize the anti-aggregatory activity of BW245C, 9 α, 11 β-PGF2, and PGD2.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201342 | 33458-93-4 | C17H14O5 | 5 mg/25 mg |
- AL 6598
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-358796 | 170291-06-2 | C23H39ClO5 | 500 µg/1mg |
- AA 2414
Thromboxane A2 (TP) receptor antagonist. Antiasthmatic agent; inhibits platelet aggregation and bronchoconstriction induced by a TXA2 mimetic in guinea pigs.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203796 | 112665-43-7 | C22H26O4 | 10 mg/50 mg |
- BAY-u 3405
Suppresses PGD2-induced migration of human eosinophils (IC50 = 170 nM). Potent dual antagonist of TP/DP2 (CRTH2) prostanoid receptors (Ki values are 4.3, 4.5 and > 10000 nM for hDP2, hTP and hDP1 receptors respectively).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-203834 | 116649-85-5 | C21H21FN2O4S | 10 mg/50 mg |
- Carbacyclin (Carbocyclic PGI2)
Carbacyclin is a stable analog of prostacyclin shown to inhibit platelet aggregation.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201250 | 69552-46-1 | C21H34O4 | 1 mg/10 mg |
- 1-(7-Carboxyheptyl)imidazole
Selective inhibitor of thromboxane synthetase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205915 | 68887-68-3 | C11H18N2O2 | 10 mg/25 mg |
- cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt
This compound reduces thromboxane A2 production. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-214735 | 73167-03-0 | C20H29NaO2 | 5 mg/10 mg |
- Cloprostenol Sodium
A synthetic F series prostaglandin that functions as a potent agonist towards the FP receptor.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201338 | 55028-72-3 | C22H28O6Cl ·Na | 1 mg/10 mg |
- 16,16-Dimethyl-prostaglandin E2
Prostaglandin E2 analog with potent cytoprotective activity and enhanced metabolic resistance yielding a longer half-life in vivo. Acts on all 4 EP receptors (EP1,2,3, and 4).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201240 | 39746-25-3 | C22H36O5 | 1 mg |
- 13,14-epoxy Travoprost
An impurity generated in the production of fluprostenol isopropyl ester.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-287303 | n.n. | C26H35F3O7 | 1 mg/5 mg |
- Fluprostenol
Fluprostenol is a prostaglandin F (FP) receptor agonist that is more selective than PGF2α (sc-201227).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201336 | 40666-16-8 | C23H29F3O6 | 1 mg/10 mg |
- GW 627368X
A selective and potent competitive antagonist of the EP4 receptor with additional human TP receptor affinity.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221702 | 439288-66-1 | C30H28N2O6S | 1 mg/5 mg |
- Latanoprost
Latanoprost is a prodrug (isopropyl ester) of 17-phenyl-13,14-dihydro prostaglandin F2α. The free acid form is a potent agonist at FP receptors. It is in clinical use as a topical antiglaucoma agent and has been shown to reduce IOP (intraoccular pressure).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201354 | 130209-82-4 | C26H40O5 | 1 mg/5 mg |
- L-798,106
Potent and highly selective prostanoid EP3 receptor antagonist (Ki values are 0.3, 916, > 5000 and > 5000 nM at EP3, EP4, EP1 and EP2 respectively). Attenuates sulprostone-induced inhibition of EFS-evoked twitch and contractile responses in vivo.
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204047 | 244101-02-8 | C27H22BrNO4S | 10 mg/50 mg |
- L-655,240
A potent inhibitor of contractions induced by prostaglandin endoperoxide analogs. Also reported to be an inhibitor of thromboxane receptors.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201350 | 103253-15-2 | C21H21ClFNO2 | 1 mg/5 mg |
- L-670,596
An orally active potent and selective thromboxane A2/prostaglandin endoperoxide receptor antagonist. Inhibits human platelet aggregation in vitro and the U-44069-induced contractions of guinea-pig trachea. Also prevents thromboxane-mediated endothelial cell death.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204041 | 121083-05-4 | C22H21F2NO4S | 10 mg |
- Misoprostol (SC-29333)
A synthetic E prostaglandin that has been shown to prevent tissue corrosion induced by certain anti-inflammatory compounds. Shown to have negative effects on the murine nervous system.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201264 | 59122-46-2 | C22H38O5 | 10 mg/100 mg |
- Ozagrel hydrochloride
Potent and selective inhibitor of thromboxane (TXA2) synthetase (IC50 = 4 nM). Does not inhibit prostacyclin (PGI2) synthetase, cyclooxygenase or PGE2 isomerase (IC50 > 1 mM). Inhibits platelet aggregation in vitro and arachidonate-induced arterial contraction in vivo.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-204153 | 74003-18-2 | C13H14N2O2.HCl | 10 mg/50 mg |
- Picotamide
Picotamide is a dually active thromboxane A2 and thromboxane A2 synthase inhibitor. It has been shown to exhibit platelet inhibitory effects ex vivo and in vitro.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201334 | 32828-81-2 | C21H10N4O3 | 10 mg/50 mg |
- 17-Phenyl-trinor-prostaglandin E2
A synthetic analog of PGE2 (sc-201225), found to be a selective EP1 and EP3 receptor agonist, unlike PGE2 which antagonizes a variety of EP receptors.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201255 | 38315-43-4 | C23H30O5 | 1 mg/10 mg |
- PTA2 (Pinane thromboxane A2)
A chemically stable, carbocyclic analog of thromboxane A2, that has been shown to act as a TP receptor antagonist which leads to coronary artery contraction and platelet aggregation induced by prostaglandin endoperoxide analogs and arachidonic acid.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201177 | 71111-01-8 | C24H40O3 | 1 mg |
- SC-51089
A selective antagonist of prostaglandin E2, which displays specificity towards the EP1 receptor subtype. This compound contains a diacylhydrazine moiety, which has often been observed to release hydrazine.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201344 | 146033-02-5 | C22H19ClN4O3 ·HCl | 5 mg/25 mg |
- SC-51322
A potent and selective prostaglandin E2 antagonist (pA2=8.1). Displays in vivo analgesic activity in the mouse (ED50=0.9 mg/kg)1. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205848 | n.n. | C22H20ClN3O4S | 5 mg/25 mg |
- SQ-29548
A compound that reversibly and competitively acts as a thromboxane A2/prostraglandin endoperoxide receptor antagonist.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201332 | 98672-91-4 | C21H29N3O4 | 1 mg/10 mg |
- Seratrodast
A potent and selective thromboxane A2 receptor antagonist with antioxidant effects. Inhibits peroxide-induced vasoconstriction in human placenta and bronchoconstriction in guinea pigs.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201352 | 112665-43-7 | C22H26O4 | 10 mg/50 mg |
- Sulprostone
A metabolism-resistant synthetic analog of PGE2, that is a selective EP3 prostanoid receptor agonist. Shown to be a potent stiumulator of uterine smooth muscle contractions.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201348 | 60325-46-4 | C23H31NO7S | 1 mg/5 mg |
- U-46619
Shown to be a potent agonist of thromboxane A2 receptor and also reported to cause constriction of coronary arteries. When bound to TXA2 receptors, this compound inhibits the release of hippocampal noradrenaline. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201242 | 56985-40-1 | C21H34O4 | 1 mg/10 mg |
|